John W Carlisle, MD in Lewiston, ID - Dermatology

John W Carlisle, MD is a Dermatology physician based in Lewiston, Idaho. John W Carlisle is licensed to practice in Idaho (license number MD8169) and his current practice location is 2315 8th St, Lewiston, Idaho. He can be reached at his office (for appointments etc.) via phone at (208) 746-1383.

NPI number for John W Carlisle is 1538242318 and his current mailing address is 2315 8th St, Lewiston, Idaho. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1538242318.

Contact Information

	John W Carlisle, MD
	2315 8th St, Lewiston, ID 83501-7301
	(208) 746-1383
	(208) 298-4521

Physician's Profile

Full Name	John W Carlisle
Gender	Male
Speciality	Dermatology
Location	2315 8th St, Lewiston, Idaho
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1538242318
Provider Enumeration Date: 10/23/2006
Last Update Date: 07/09/2007

Medical Identifiers

Medical identifiers for John W Carlisle such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1538242318	NPI	-	NPPES
8147845	Medicaid	WA
145739	Other	WA	WA LABOR & INDUSTRIES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207N00000X	Dermatology	MD8169 (Idaho)	Primary
207N00000X	Dermatology	MD00012692 (Washington)	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. John W Carlisle is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
John W Carlisle, MD 2315 8th St, Lewiston, ID 83501-7301 Ph: (208) 746-1383	John W Carlisle, MD 2315 8th St, Lewiston, ID 83501-7301 Ph: (208) 746-1383

News Archive

Coherex Medical raises $16.5 million from venture capital firms

Coherex Medical, Inc. today announced that it has closed a $16.5 million Series B Preferred Stock financing. After the close of this investment, Coherex has now raised nearly $28.0 million in equity financing from outside funding sources since inception.

Using MDRS to accelerate deformulation: a new whitepaper from Malvern Instruments

A new whitepaper from Malvern Panalytical on Oral Solid Dose (OSD) deformulation demonstrates how the analytical technique of Morphologically Directed Raman Spectroscopy (MDRS) can be used to accelerate the development of generic products to a successful conclusion.

Hormone therapy does not safeguard post-menopausal women against cardiovascular disease

New evidence published today in the Cochrane Library shows that hormone replacement therapy does not protect post-menopausal women against cardiovascular disease, and may even cause an increased risk of stroke.

Insured Americans are using fewer medical services while employers consider wellness incentives

Insured Americans are using fewer medical services, raising questions about whether patients are consuming less health care as they pick up a greater share of the costs. The drop in usage is showing up as health-care companies report financial results. Insurers, lab-testing companies, hospitals and doctor-billing concerns say that patient visits, drug prescriptions and procedures were down in the second quarter from year-ago levels. Others say that consumers are beginning to forgo elective procedures like knee replacements.

John W Carlisle, MD - Dermatology in Lewiston, ID